The findings place GLIS3 upstream of a core astrocyte transcriptional program in the experimental systems examined. Beyond controlling established differentiation markers, the factor influenced genes associated with glutamate and potassium homeostasis, synaptic transmission and synapse formation, linking astrocyte identity with several cellular processes important to brain function.

The researchers first assessed GLIS3 expression in mouse-derived astrocytes using reverse-transcription quantitative polymerase chain reaction and immunofluorescence. Both methods showed robust expression, establishing that the transcription factor is present in the cells used to investigate its relationship with astrocyte biology.

They then generated GLIS3-knockout human embryonic stem cells and examined the effects on astrocyte differentiation. Loss of GLIS3 markedly reduced the expression of canonical astrocyte markers. This result connected the molecular perturbation to a broad failure to induce astrocyte characteristics rather than to a change involving only one measured marker.

The investigators also tested whether restoring GLIS3 could reverse the differentiation defect. Introducing exogenous GLIS3 restored induction of astrocyte-specific genes, providing experimental evidence that GLIS3 is required for the astrocyte lineage program in this human stem-cell system.

Integrative transcriptomic and cistromic analyses indicated that GLIS3 directly controls part of the core astrocyte transcriptional program, including GFAP, SLC1A2, NFIA and ATF3. The analyses also showed that GLIS3 acts together with lineage-determining factors such as STAT3, NFIA and SOX9, placing the factor within a broader network of gene regulation.

Pathway analysis identified additional GLIS3-dependent genes, including SLC1A2, GRIA4, GRIA2, SLC38A2 and KCNJ10. The researchers associated these genes with glutamate and potassium homeostasis, synaptic transmission and synapse formation. These findings indicate that GLIS3 regulates astrocyte differentiation alongside genes involved in several neural signaling processes, although the experiments do not establish effects on neurological disease in patients.

The study is mechanistic and was conducted in mouse-derived astrocytes and human embryonic stem cells. It supports the conclusion that GLIS3 regulates astrocyte differentiation and gene expression in these systems, but it does not demonstrate that changing GLIS3 activity can prevent or reverse neurodegenerative disease in people. The authors identify GLIS3 as a potential therapeutic target for astrocyte-associated neurological disorders, a prospect that would require further validation.

Subject of Research: Experimental regulation of astrocyte differentiation and gene expression by GLIS3 in mouse-derived astrocytes and human embryonic stem cells.

Article Title: GLIS3 is a key transcriptional regulator of astrocyte differentiation in human neural stem cells

Article References: Pradhan, T., Kang, H. S., Jeon, K., Grimm, S. A., Park, K.-Y., Gruzdev, A., & Jetten, A. M. (2026). GLIS3 is a key transcriptional regulator of astrocyte differentiation in human neural stem cells. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06482-w

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06482-w

Keywords: GLIS3, astrocyte differentiation, human embryonic stem cells, transcription factor, gene regulation, neural homeostasis, glutamate homeostasis, potassium homeostasis, synaptic transmission, neurodegenerative disease, transcriptional, regulator

The story began with alpha-dystrobrevin-1, a cytoplasmic component of the dystrophin-glycoprotein complex, or DGC, a macromolecular assembly that anchors proteins at the muscle membrane to the extracellular matrix and the cytoskeleton. Mutations in several DGC components cause severe, often fatal muscular dystrophies, yet the molecular functions of many of its parts remain incompletely understood. Earlier proteomics work by the same group had identified SH3BP2 as a candidate binding partner recruited to a specific phosphorylated tyrosine residue, Y713, on alpha-dystrobrevin-1. Because SH3BP2 had never been studied in skeletal muscle, the team, led by Tomasz J. Prószyński of Łukasiewicz Research Network–PORT and the Nencki Institute of Experimental Biology, decided to find out what this adapter protein was doing at the synapse.

The first surprise was location. When the researchers immunostained muscle fibers from the tibialis anterior, they found strong SH3BP2 immunoreactivity concentrated precisely at the postsynaptic machinery of the neuromuscular junction, overlapping with the acetylcholine receptors. Electroporating a GFP-tagged version of the protein into living muscle confirmed the enrichment, showing a punctate signal at the junctions where control GFP showed none. Biochemical experiments then established that the interaction with alpha-dystrobrevin-1 is direct and phospho-dependent: synthetic peptides carrying phosphorylated Y713 efficiently pulled down purified SH3BP2, while the unphosphorylated version and a second phosphorylation site, Y730, did not. Domain mapping showed that the C-terminal SH2 domain, a module classically known for binding phosphorylated tyrosines, mediated this specific interaction.

What makes SH3BP2 unusual is its polyvalency. The protein contains three recognizable domains, an N-terminal pleckstrin homology domain, a central proline-rich region, and the SH2 domain, plus a predicted intrinsically disordered region. When the team expressed each domain individually in muscle, all three still targeted the neuromuscular junction, suggesting that each one grips a different postsynaptic partner. Mass spectrometry of proteins pulled down by purified SH3BP2 from cultured myotubes identified several components of the dystrophin-glycoprotein complex, including utrophin, dystrophin, and alpha- and beta-syntrophins, as well as the acetylcholine receptor subunits alpha and gamma and the agrin receptor Lrp4. Co-immunoprecipitation confirmed binding to syntrophin-1 and beta-dystroglycan, the transmembrane core that assembles the entire complex.

The most striking finding, however, concerned the acetylcholine receptor itself. Each receptor pentamer contains two copies of the alpha subunit, and SH3BP2 turned out to bind the long cytoplasmic loop of this subunit at three distinct sites, one for each of its domains. The SH2 domain docked on the most N-terminal segment, the proline-rich region on the next, and the PH domain on the third. Rapsyn, the major receptor-clustering scaffold, bound a completely different, C-terminal set of peptides, meaning the two scaffolds grip the receptor from opposite ends. Purified GST-tagged receptor loop directly captured SH3BP2 from cell extracts, and labeling surface receptors in live myotubes with biotinylated bungarotoxin showed that endogenous SH3BP2 co-precipitates with the receptor complex, confirming the interaction in muscle cells.

To test whether this web of interactions matters functionally, the researchers silenced SH3BP2 in C2C12 myotubes using two independent siRNAs. When the depleted cells were grown on laminin-111 or treated with agrin, both established triggers of receptor clustering, they formed dramatically fewer acetylcholine receptor clusters, with more than a fifty percent reduction under agrin treatment. Crucially, precipitation experiments showed that the total amount of receptor and the amount reaching the cell surface were unchanged. The problem was not receptor production or trafficking but the cell’s ability to gather receptor molecules into dense assemblies at the plasma membrane, pointing to a specific scaffolding defect rather than a general failure of muscle differentiation.

The in vivo experiments extended the story across the entire lifespan of the synapse. The team generated mice lacking SH3BP2 specifically in skeletal muscle by crossing a conditional knockout strain with Myf5-Cre mice. At embryonic day 13.5, before motor axons reach most of the muscle, mutant diaphragms formed significantly fewer of the spontaneously arising receptor hot spots that seed synapse formation, demonstrating a nerve-independent role for the protein. By postnatal day 15, during intense synaptic remodeling, junctions in mutant muscle showed reduced endplate size, reduced receptor-occupied area, and enlarged perforations. In adult animals, the neuromuscular junctions were markedly more fragmented, with an almost fourfold increase in regions where acetylcholinesterase remained exposed after receptors had been removed, a molecular fingerprint of receptor loss from the synapse.

Electron microscopy revealed that the damage ran deeper than the light microscope could see. Normal junctional folds concentrate receptors at their crests and sodium channels in their depths, an arrangement that amplifies the endplate potential into a muscle action potential. In the mutant mice, the folds were exuberantly long and thick, the synaptic cleft was wider, and the electron-dense postsynaptic machinery was often displaced from the crests into the depths of the folds, a compensatory pattern previously seen in animals with reduced rapsyn or lacking alpha-dystrobrevin. These ultrastructural abnormalities help explain why the synapses failed under load: basal transmission was intact, with normal single-pulse endplate potentials and normal compound muscle action potentials at low frequencies, but repetitive stimulation at 50 hertz produced a roughly fifty percent increase in the compound muscle action potential decrement, and single-fiber recordings showed increased fatigue at 20 hertz.

Functional testing tied the synaptic defects directly to weakness. Mutant mice had significantly lower grip strength, ran shorter distances on voluntary running wheels, and exhausted earlier on an accelerating treadmill, reaching lower maximal speeds than controls. Yet histological analysis of muscle cross-sections showed normal fiber morphology and area, and serum creatine kinase levels, a marker of muscle damage, were unchanged. Direct force measurements made the picture precise: when the tibialis anterior muscle was stimulated directly, tetanic force was only mildly reduced, but when the sciatic nerve was stimulated, forcing the signal through the neuromuscular junction, the force deficit became large and significant at every frequency tested. The weakness, in other words, is synaptic, not muscular.

The study positions SH3BP2 as a peripheral member of the dystrophin-glycoprotein complex whose loss disrupts synaptic architecture without triggering muscular dystrophy, mirroring the behavior of syntrophin-1 and utrophin. It also raises intriguing questions beyond the synapse: SH3BP2 was detected in a striated pattern along muscle fibers resembling costameres, the structures that couple contractile machinery to the membrane, and its known association with podosomes in macrophages hints at roles in actin remodeling that the proteomics data partially echo. The authors suggest that future work in aging cohorts and disease models will be needed to determine whether SH3BP2’s contribution to synaptic robustness becomes more consequential as neuromuscular junctions deteriorate with age or disease. For now, the finding adds a new layer to the molecular blueprint of the synapse where brain meets muscle, and identifies a scaffold whose grip on the acetylcholine receptor turns out to be, quite literally, what holds strength together.

Subject of Research: The role of the scaffold protein SH3BP2 in acetylcholine receptor clustering and neuromuscular junction organization in skeletal muscle

Article Title: SH3BP2 deficiency in skeletal muscle leads to neuromuscular junction abnormalities and decreased muscle strength

Article References: Pradhan, B. S., Bernadzki, K. M., Bandaruk, Y., Siudzińska, A., De Cicco, T., Sotomska, M., Gawor, M., Jabłońska, M., Krzemień, J., Chodaczek, G., Hashemolhosseini, S., & Prószyński, T. J. (2026). SH3BP2 deficiency in skeletal muscle leads to neuromuscular junction abnormalities and decreased muscle strength. Frontiers in Molecular Neuroscience, 19, Article 1985823. https://doi.org/10.3389/fnmol.2026.1985823

Image Credits: AI Generated

DOI: 10.3389/fnmol.2026.1985823

Keywords: SH3BP2, neuromuscular junction, acetylcholine receptors, skeletal muscle, dystrophin-glycoprotein complex, alpha-dystrobrevin-1, rapsyn, synaptic transmission, muscle strength, knockout mice, scaffold protein, molecular neuroscience

The study, published in BMC Psychiatry, enrolled 66 patients with systemic lupus erythematosus and 33 healthy volunteers, all recruited from Taizhou People’s Hospital. Participants underwent neuropsychological assessment and resting-state functional magnetic resonance imaging, a technique that records brain activity while subjects lie still and think of nothing in particular. Rather than treating this spontaneous activity as a static signal, the team focused on a measure called dynamic regional homogeneity, or dReHo. Regional homogeneity reflects how synchronized the activity of neighboring voxels is at any given moment; high homogeneity suggests that a local patch of cortex is firing in a coordinated fashion, while low homogeneity suggests disarray. By computing this metric across sliding time windows, the researchers could track how that local coordination fluctuates over the course of a scan, capturing a dimension of brain function that conventional static analyses miss entirely.

The results were striking. Seven brain regions showed abnormal dynamic regional homogeneity in the lupus patients compared with healthy controls: the left gyrus rectus, the left and right middle temporal gyri, the left and right middle occipital gyri, the left precuneus, and the right calcarine fissure. What unites most of these regions is their role in vision. The calcarine fissure is the cortical landing strip for signals arriving from the eyes, the primary visual processing hub of the brain, while the middle occipital and middle temporal gyri form successive stages of the visual hierarchy, extracting motion, form, and spatial relationships from the raw retinal input. The precuneus, tucked into the medial parietal lobe, weaves visual and memory signals into self-referential thought and social cognition, and the gyrus rectus on the underside of the frontal lobe contributes to emotional and social processing. Functional annotation of the affected regions confirmed this impression, linking the abnormality map primarily to social cognition and visual processing.

Identifying where the brain behaves abnormally is only half the story. The deeper question is why those particular regions, and not others, are vulnerable in lupus. To address this, the team turned to an increasingly popular strategy known as imaging transcriptomics. The Allen Human Brain Atlas provides gene expression data from postmortem tissue sampled across the entire cerebral cortex, and researchers can ask whether the spatial fingerprint of an imaging abnormality, region by region, tracks the spatial fingerprint of any particular set of genes. If brain areas with high expression of a certain gene family are precisely the areas showing the greatest functional disruption, that gene family becomes a plausible molecular suspect. It is an inferential approach, and the authors are careful to describe their findings as hypothesis-generating, but it offers something that pure imaging studies cannot: a bridge from circuits to molecules.

The transcriptomic analysis pointed in a coherent direction. Genes whose cortical expression patterns matched the dReHo alteration map were significantly enriched for functions related to chemical synaptic transmission, the fundamental mechanism by which neurons communicate across the tiny gaps between them. The map also aligned with markers of excitatory neurons, the workhorse cells that drive cortical activity, and with genes preferentially expressed in the visual cortex. Two specific excitatory neuron subclasses stood out: Ex3-Granule-L4 cells, which populate the middle layer of the cortex where sensory input first arrives, and Ex8-Corticothalamic-Projecting-L6 cells, which send feedback from deep cortical layers back down to the thalamus, the brain’s relay station. In other words, the regions most affected in lupus are those built around a dense machinery of excitatory synaptic transmission in the sensory processing stream, suggesting that the disease may be disrupting the very synapses that carry visual and social information through the cortex.

The team went further, correlating the dReHo abnormality map with molecular maps of neurotransmitter systems, each derived from independent imaging and pharmacological data. Eight systems showed meaningful spatial correspondence: the dopamine transporter DAT, the serotonin receptors 5-HT2A and 5-HT6, the inhibitory transmitter GABA, the kappa-opioid receptor, the muscarinic acetylcholine receptor M1, the synaptic vesicle glycoprotein SV2A, and histone deacetylase, or HDAC. Each of these carries its own implications. Serotonin and dopamine are the classic targets of psychiatric pharmacology, and their involvement hints at why lupus patients experience depression, anxiety, and psychosis. GABA is the brain’s principal brake, and a relative loss of inhibitory control could explain the local desynchronization captured by the dReHo metric. SV2A marks the density of synaptic terminals themselves, while HDAC sits at the interface between gene regulation and inflammation, a pathway of particular interest in autoimmune disease.

For clinicians, the study offers a potential explanation for a frustrating clinical reality. Many neuropsychiatric lupus symptoms, from subtle cognitive slowing to visual disturbances and difficulty reading social cues, have historically been attributed to vascular injury, antibody-mediated inflammation, or the psychological burden of chronic illness, yet objective biomarkers have remained scarce. The finding that dynamic local coordination is disrupted specifically in visual and social cognition networks suggests that some of these symptoms may have a measurable functional signature, one that could in principle be detected with a standard resting-state MRI scanner already installed in most hospitals. The involvement of the visual cortex is especially provocative, because visual complaints in lupus are often dismissed as peripheral, confined to the eye itself, when the new data suggest that the brain’s central visual machinery may be quietly reorganizing.

The authors are appropriately measured about what their results can and cannot claim. The sample, while respectable for a study of this kind, comprised 66 patients and 33 controls from a single center, and the imaging-transcriptomic method is correlational by design: it identifies spatial associations between gene expression and functional disruption but cannot prove that any particular gene or neurotransmitter causes the abnormalities. The dReHo alterations could reflect downstream consequences of inflammation, vascular compromise, medication effects, or the immune assault itself, and disentangling these mechanisms will require longitudinal studies that follow patients from disease onset through treatment. Still, the framework is powerful. By anchoring a functional imaging phenotype to synaptic transmission genes, specific excitatory neuron classes, and eight distinct neurotransmitter systems, the study generates a ranked list of molecular targets that pharmacologists and immunologists can now interrogate.

What makes the work emblematic of a broader shift in neuroscience is its methodological synthesis. A decade ago, a rheumatology question would rarely have been answered with a brain atlas of gene expression; today, the tools exist to overlay a patient group’s functional abnormality map onto the transcriptomic landscape of the cortex and read out candidate biology in a single analysis. The Taizhou team’s integration of dynamic fMRI metrics, the Allen Human Brain Atlas, neurotransmitter receptor maps, and single-cell-derived neuron subclass data represents exactly the kind of multi-scale approach that is reshaping how researchers study neuropsychiatric disease. For the estimated millions of people worldwide living with lupus, and particularly for the substantial fraction who experience neurological or psychiatric complications, the study offers something intangible but important: evidence that the fog of neuropsychiatric lupus has structure, that it follows the brain’s molecular geography, and that with the right combination of imaging and genomics, that geography can finally be mapped.

Subject of Research: Dynamic brain activity changes and their transcriptomic correlates in neuropsychiatric systemic lupus erythematosus

Article Title: Dynamic regional homogeneity changes and their genetic correlates in neuropsychiatric systemic lupus erythematosus: a combined transcriptome-neuroimaging study

Article References: Pu, X., Li, Y., Sun, Z., Liu, Y., Ji, W., Yin, X., Wu, Q., Dong, L., Zou, H., Zhang, J., & Xia, J. (2026). Dynamic regional homogeneity changes and their genetic correlates in neuropsychiatric systemic lupus erythematosus: a combined transcriptome-neuroimaging study. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08653-2

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08653-2

Keywords: neuropsychiatric lupus, systemic lupus erythematosus, resting-state fMRI, dynamic regional homogeneity, imaging transcriptomics, Allen Human Brain Atlas, visual cortex, synaptic transmission, neurotransmitters, excitatory neurons, autoimmune disease, brain mapping

For decades, the dominant explanation was simple: muscles shrink with age, a condition known as sarcopenia, and smaller muscles produce less force. But population data have long revealed a puzzle. Strength declines at a substantially faster rate than muscle mass itself, which means that atrophy alone cannot account for the full loss of power. This discrepancy has pushed researchers to look beyond the muscle and toward the nervous system, which is required to generate and sustain muscular force. Most of that work has focused on the spinal cord and the periphery, where scientists have well characterized changes in spinal circuit excitability, motor neuron intrinsic properties, synaptic balance, and the transmission and remodeling of the neuromuscular junction, the synapse where nerves talk to muscle fibers.

Far less attention has been paid to the motor cortex, the region of the brain’s outer layer that serves as the cortical source of voluntary movement. Human studies have pointed to decreased voluntary activation of limb muscles in older adults, along with altered cortical output to muscle and imbalances between excitatory and inhibitory circuits in the motor cortex. But human imaging and stimulation techniques lack the resolution to identify which specific cortical circuits, neuronal populations, or molecular mechanisms change with aging, or to tie those changes directly to motor dysfunction. A new study in aged mice, published in the journal Aging Cell, set out to close that gap by measuring brain, nerve, and muscle function in the very same animals.

The research team, based at the University of Missouri, built on their own earlier discovery that layer V pyramidal neurons of the primary motor cortex become hyperexcitable in aged mice. These neurons are a heterogeneous population of deep-layer projection cells that includes the neurons responsible for transmitting and shaping cortical motor commands to the spinal cord. The finding was striking because cortical hyperexcitability mirrors what is seen in neurodegenerative diseases such as amyotrophic lateral sclerosis, where it has been implicated in motor decline, and Alzheimer’s disease, where it has been linked to cognitive deterioration. The question was whether this hyperexcitability in aging is merely a curiosity or is genuinely coupled to weakness.

To answer it, the researchers ran an unusually comprehensive battery of tests on young mice aged three months and aged mice aged 24 months, with equal numbers of males and females in each group. Behavioral testing showed that aged mice were dramatically weaker: grip strength, rotarod coordination, and a demanding weighted cart pull task were all significantly reduced. In vivo electrophysiology revealed that the compound muscle action potential, a measure of overall neuromuscular excitability, was smaller in aged animals, as was the estimated number of functioning motor units, while individual motor units were larger and repetitive nerve stimulation revealed greater transmission failure at the neuromuscular junction. Direct measurements of muscle contractility confirmed that both twitch and tetanic plantar flexion torque were substantially reduced in the aged animals.

The most provocative result came from motor evoked potential recordings, which measure the brain’s output to muscle. When the researchers stimulated across the motor cortex, the evoked response in the gastrocnemius muscle was larger in aged mice, indicating enhanced cortical output. In contrast, stimulation at the cervical spinal cord produced smaller responses in aged animals, indicating reduced spinal output. In other words, the aged nervous system showed a paradoxical signature: a weakening spinal and neuromuscular apparatus accompanied by a louder signal coming down from the cortex. This pattern suggested that the hyperexcitable cortical neurons the team had identified previously might be actively reshaping the motor system rather than passively reflecting its decline.

Patch-clamp recordings from 160 individual layer V pyramidal neurons across the same animals confirmed the intrinsic hyperexcitability. Aged neurons fired more vigorously at every depolarizing current step tested, from 50 to 300 picoamperes, roughly doubling their firing frequency at both low and high stimulation. Their membranes were also more resistive and had longer time constants, properties that reduce the current needed to reach the threshold for an action potential. Single-cell molecular analysis using digital PCR revealed that aged neurons carried elevated transcript levels of Nav1.6 and Nav1.1, sodium channel subunits that carry the persistent inward current, a powerful amplifier of repetitive firing, as well as increased levels of the serotonin receptor 5-HT2C, a known modulator of that current. These transcriptional changes provide candidate molecular markers of the hyperexcitable phenotype.

Synaptic recordings added another layer of mechanism. When the researchers stimulated layer II/III of the motor cortex, the canonical source of feedforward drive onto layer V neurons, they found that excitatory inputs onto aged neurons showed an increased paired-pulse ratio, indicating reduced initial release probability but a capacity to sustain transmission during high-frequency activity. Inhibitory inputs showed the opposite pattern: smaller evoked responses and a decreased paired-pulse ratio, suggesting that inhibitory synapses release strongly on the first pulse but deplete rapidly during repeated activation. This combination could allow excitatory drive to dominate during the sustained, high-frequency firing that characterizes voluntary movement, potentially feeding and maintaining the hyperexcitable state.

The statistical centerpiece of the study came from correlating all of these measurements within individual animals. Across 250 pairwise relationships between cortical variables and neuromuscular or behavioral outcomes, 109 were statistically significant after correction for multiple comparisons, and the large majority were negative, meaning that animals with higher cortical excitability tended to have worse motor outcomes. Firing frequency at 50 picoamperes emerged as the single strongest cortical correlate of a composite neuromuscular dysfunction index, explaining 90 percent of its variance. A mediation analysis then showed that this firing frequency statistically accounted for 75 percent of the effect of aging on neuromuscular function, although a reverse model, in which the mediator and outcome were swapped, accounted for a smaller 42.2 percent, underscoring that observational data of this kind cannot establish causal direction.

The authors are careful on this point: the mediation models represent a statistical decomposition of variance, not proof that cortical hyperexcitability causes weakness. It remains possible that the brain’s overactive output is a compensatory response to a failing periphery, or that both phenomena flow from a common aging process. Still, recent evidence that chemogenetically inducing layer V hyperexcitability in the motor cortex reduces muscular force and coordination in mice raises the possibility that the phenotype is maladaptive. The parallels with ALS, where cortical hyperexcitability is a well-established feature associated with downstream motor deficits, suggest it may be a shared mechanism across distinct contexts of motor dysfunction. If future experiments show that dampening layer V hyperexcitability in aged animals restores strength, the motor cortex could emerge as a genuine therapeutic target for one of aging’s most burdensome consequences, transforming weakness from an inevitable decline into a treatable disorder of brain circuitry.

Subject of Research: Motor cortex hyperexcitability and its relationship to neuromuscular dysfunction in aged mice

Article Title: Motor Cortex Hyperexcitability Is Coupled to Neuromuscular Dysfunction in Aged Mice

Article References: Viteri, J. A., Kerr, N. R., Darvishi, F. B., Dashtmian, A. R., Brennan, C. D., Ayyagari, S. N., Moore, P. J., Wang, M., Snyder, H., Yu, B., Santin, J. M., & Arnold, W. D. (2026). Motor Cortex Hyperexcitability Is Coupled to Neuromuscular Dysfunction in Aged Mice. Aging Cell, 25(10), Article e70731. https://doi.org/10.1111/acel.70731

Image Credits: AI Generated

DOI: 10.1111/acel.70731

Keywords: aging, motor cortex, muscle weakness, sarcopenia, layer V pyramidal neurons, hyperexcitability, neuromuscular junction, patch clamp, persistent inward current, ALS, synaptic transmission, electrophysiology

AMPA receptors, or AMPARs, are tetrameric ion channels assembled from four subunits. When glutamate binds, the channel opens into distinct conductance states, each corresponding to a different number of bound glutamate molecules. Textbook models hold that receptors lacking the GluA2 subunit behave in a characteristic way: they conduct calcium, show inward rectification of their current-voltage relationship, and are blocked by intracellular polyamines such as spermine. These hallmark properties have long been used as diagnostic fingerprints, allowing scientists to infer the subunit composition of receptors at a given synapse simply by measuring rectification or calcium permeability. The new work shows that this inference can be dangerously misleading, because the same receptor can display dramatically different properties depending on how much glutamate reaches it.

The team focused on molecular layer interneurons in the mouse cerebellum, a preparation with a decisive experimental advantage. These interneurons receive two anatomically distinct excitatory inputs, from parallel fibers and climbing fibers, onto the same population of AMPA receptors. Previous work from the same laboratories had established that these two pathways deliver different glutamate transients: parallel fiber synapses generate high local glutamate concentrations, whereas climbing fiber signals rely partly on spillover of glutamate that diffuses from neighboring release sites, arriving at lower effective concentrations. Because the receptors themselves are shared, any difference in receptor behavior between the two pathways could not be attributed to subunit composition, providing a clean test of whether ambient glutamate concentration alone can tune receptor function.

The answer was unambiguous. Recording excitatory postsynaptic currents from the two pathways, the researchers found that parallel fiber responses showed strong inward rectification, a signature of polyamine block, while climbing fiber responses at the same cells were far more linear. The kynurenic acid experiments reinforced the point: this competitive antagonist inhibited climbing fiber EPSCs less than parallel fiber EPSCs, exactly what one expects if climbing fiber signals are carried by lower glutamate transients. Crucially, the differences persisted under near-physiological extracellular calcium, were unaffected by blocking desensitization with cyclothiazide, and remained in mice lacking the auxiliary subunit TARP gamma-2, ruling out the most obvious alternative explanations.

To manipulate glutamate concentration directly, the team turned to two-photon glutamate uncaging. By positioning the uncaging spot at different distances from the recorded interneuron and varying laser power, they could dial the effective glutamate concentration up or down at will. Lowering the effective concentration systematically increased the rectification index, moving responses toward the linear, low-rectification phenotype normally associated with GluA2-containing receptors. Conversely, high concentrations produced strong rectification. The same manipulation also changed estimates of unitary conductance, with higher glutamate yielding larger single-channel conductance values. In other words, a measurement that neuroscientists routinely interpret as a subunit fingerprint was tracking the glutamate landscape instead.

Calcium permeability told the same story. AMPA receptors lacking GluA2 admit calcium, and the ratio of calcium influx to total current is another widely used indicator of receptor identity. The researchers showed that calcium permeability itself depended on glutamate concentration, with lower concentrations reducing calcium influx relative to current. Even in mice with conditional deletion of GluA2, where all receptors are calcium-permeable by construction, the apparent calcium signals varied with the glutamate transient. The implication is striking: the same molecular receptor can appear more or less calcium-permeable depending on the synaptic conditions under which it is activated.

To understand the mechanism, the investigators moved to reduced preparations. They isolated AMPA receptors in outside-out patches from the interneurons and from HEK cells expressing only the GluA1 subunit, then applied rapid jumps to glutamate concentrations ranging from 30 micromolar to 10 millimolar. At low concentrations, rectification weakened even though intracellular spermine was present, indicating that the polyamine block itself was state-dependent. The key insight is that spermine binds preferentially to certain conductance states of the channel. At low glutamate, receptors occupy subconductance states with lower spermine affinity, so the block is relieved and the current-voltage relationship straightens. At high glutamate, receptors favor fully liganded, high-conductance states that are strongly blocked by spermine, producing the classic inward rectification.

The team formalized this idea with a kinetic model in which glutamate binds sequentially to four independent subunits, each binding step opening the channel to a different conductance level, and spermine block differs across those levels. Simulations of the model reproduced the full range of rectification indices observed experimentally as a function of glutamate concentration, and the predicted state occupancies shifted exactly as the recordings demanded. The model thus establishes conductance-state occupancy as the mechanistic bridge between the synaptic glutamate landscape and receptor behavior, providing a quantitative framework that other laboratories can now apply to their own preparations.

The broader implications reach well beyond the cerebellum. Synaptic glutamate concentration is not fixed; it varies with release probability, vesicle filling, the number of vesicles released, the geometry of the cleft, and the activity of glutamate transporters in neurons and astrocytes. Spillover transmission, multivesicular release, and activity-dependent changes in transporter function all modulate how much glutamate reaches a receptor and for how long. The new findings mean that such modulation does not merely change the size of synaptic currents but can alter their apparent rectification, conductance, and calcium permeability, properties that the field has used for thirty years to read out receptor subunit composition. Studies interpreting rectification as evidence for subunit switching during plasticity, or for changes in GluA2 content in disease, may need to be reexamined through this new lens.

There is also a conceptual payoff. Excitatory signaling in neural circuits has generally been framed as a dialogue between presynaptic release and postsynaptic receptor identity, with auxiliary proteins and phosphorylation adding layers of modulation. This study adds the extracellular transmitter concentration itself as an active determinant of channel function, effectively making the microenvironment of the synapse a participant in the computation. The authors, funded by the National Institutes of Health and publishing with data and code openly available on GitHub and Zenodo, suggest that the synaptic glutamate landscape dynamically shapes AMPAR signaling in ways previously unrecognized. If glutamate concentration can retune the same receptors from within the normal operating range of synapses, then the brain possesses a form of analog control over its fastest connections that no one had thought to measure, and a whole dimension of synaptic regulation is now open for exploration.

Subject of Research: How synaptic glutamate concentration tunes AMPA receptor biophysical properties through conductance-state occupancy

Article Title: Glutamate concentration tunes AMPA receptor function through conductance-state occupancy

Article References: Banumurthy, G., Pennock, R. L., Coddington, L. T., Yan, X., Smith, G. N., Overstreet-Wadiche, L., & Wadiche, J. I. (2026). Glutamate concentration tunes AMPA receptor function through conductance-state occupancy. Nature Neuroscience. https://doi.org/10.1038/s41593-026-02414-w

Image Credits: AI Generated

DOI: 10.1038/s41593-026-02414-w

Keywords: AMPA receptors, glutamate, synaptic transmission, conductance states, polyamine block, calcium permeability, rectification, cerebellum, interneurons, ion channels, neurotransmitters, molecular biophysics

The research, led by Newton and colleagues and published in Nature Structural & Molecular Biology, takes advantage of a long-standing puzzle in receptor biophysics. Full agonists such as glutamate drive AMPA receptors to high open probabilities, whereas partial agonists, including the willardiine derivatives that bind in the same ligand-binding pocket but occupy it incompletely, produce smaller responses. Electrophysiologists have known for years that partial agonists generate smaller currents largely because they destabilize the open state rather than slow channel opening itself, but the structural intermediates through which agonist efficacy is transduced into pore opening were poorly defined. The new work closes this gap by trapping the receptor in these intermediates and imaging them directly, revealing that the pre-active state is not a vague abstraction but a discrete, resolvable structural ensemble with its own characteristic domain arrangement.

To visualize the pathway, the team employed time-resolved cryo-electron microscopy, a technique that flash-freezes protein samples at defined intervals after agonist application, effectively capturing molecular movies of the receptor as it transitions between states. By applying full and partial agonists and freezing the samples at early time points, the researchers were able to arrest the receptor population at different stages along the activation trajectory. Classification and reconstruction of the resulting particle images then separated the heterogeneous mixtures into distinct conformational classes corresponding to the resting, pre-active, and open states. This strategy allowed the authors to assemble an ordered sequence of structures that collectively describe the gating cycle, something that conventional single-state cryo-EM snapshots had been unable to deliver because the intermediate states are transient and sparsely populated at equilibrium.

The resulting structures reveal that AMPA receptor activation is a highly coordinated, multi-step process. In the resting state, the extracellular ligand-binding domains, which form a dimer-of-dimers architecture in the tetrameric receptor, adopt an extended configuration, and the transmembrane channel-lining helices are held shut. Upon agonist binding, each ligand-binding domain clamshell closes around its ligand, but the structures show that clamshell closure alone is not sufficient to open the pore. Instead, the receptor passes through the pre-active state, in which the ligand-binding domains have begun to rearrange and the interfaces between subunits have weakened in a specific, asymmetric pattern, while the transmembrane gate remains closed. This intermediate represents the structural link between ligand binding and gate opening, and its resolution provides the first complete structural description of how binding energy is accumulated before the pore expands.

One of the most striking findings of the study concerns the role of symmetry and subunit cooperativity. AMPA receptors are tetramers assembled from four subunits, and the new structures demonstrate that the four ligand-binding domains do not move in lockstep. Instead, activation proceeds through partially occupied and asymmetric configurations in which different subsets of subunits contribute to the driving force for opening at different stages. Full agonists stabilize configurations in which all four ligand-binding domains have closed and the intersubunit interfaces have rearranged sufficiently to pull the M3 gate helices apart. Partial agonists, by contrast, fail to stabilize the same set of interactions, leaving the receptor more frequently stranded in or near the pre-active state rather than progressing to the open state. This observation provides a direct structural explanation for the classical electrophysiological finding that partial agonists reduce open probability without substantially slowing activation kinetics.

The study also clarifies how the energy of ligand binding is transmitted across the membrane. The structures trace a continuous mechanical pathway from the ligand-binding core, through the linker peptides that connect the ligand-binding domains to the transmembrane region, and into the M3 segments that form the activation gate. In the pre-active state, this pathway is under tension: the ligand-binding cores have moved, but the gate has not yet followed. The authors’ analysis shows that the transition from the pre-active state to the open state involves a concerted rearrangement of the linkers and an expansion of the gate, which widens the ion-conducting pore to a diameter compatible with rapid cation flow. The completeness of this structural trajectory, from free receptor to agonist-bound pre-active state to open channel, means that researchers can now assign specific conformational changes to specific steps in the energy landscape of gating.

These findings have broad implications for understanding both normal synaptic transmission and neurological disease. AMPA receptor dysfunction has been implicated in epilepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, and a range of psychiatric conditions, and the receptors are major drug targets. Positive allosteric modulators of AMPA receptors, known as ampakines, act by stabilizing specific states along the gating pathway, and allosteric toxins and endogenous modulators likewise exert their effects by shifting the energetic balance between closed, pre-active, and open configurations. With the pre-active state now structurally defined, drug developers have a new and strategically important conformational target: molecules that stabilize or destabilize this intermediate could fine-tune synaptic strength with an unprecedented degree of control, potentially treating hyperexcitability or cognitive impairment by adjusting how easily receptors cross the final activation barrier.

The work also serves as a methodological demonstration of what time-resolved cryo-electron microscopy can achieve for ion channel biology. AMPA receptors, like many ligand-gated channels, are dynamic machines whose most interesting states are the least stable ones. By combining rapid mixing and freezing with sophisticated image classification, the study shows that even sparsely populated, millisecond-scale intermediates can be captured and resolved. The approach, the authors note, should be readily transferable to other members of the ionotropic glutamate receptor family, including NMDA and kainate receptors, as well as to related tetrameric channels, promising a more complete mechanistic picture of excitatory signaling throughout the nervous system. It also complements electrophysiology and molecular dynamics simulations by anchoring computational models to experimentally determined intermediate structures.

In synthesizing full and partial agonist data across multiple time points, the study delivers what receptor biophysicists have sought since AMPA receptors were first cloned: a structurally grounded, stepwise model of activation that connects ligand chemistry to pore conductance. The pre-active state, once an enigmatic placeholder in kinetic schemes, is now a defined three-dimensional entity with measurable intersubunit interfaces, linker tensions, and gate geometry. As researchers begin to exploit this intermediate in drug discovery and mutagenesis studies, the complete gating pathway of AMPA receptors will likely serve as a paradigm for how molecular machines convert chemical signals into electrical events, a conversion that underlies every thought, sensation, and movement the brain produces.

Subject of Research: Structural mechanism of AMPA receptor gating and pre-activation revealed by time-resolved cryo-electron microscopy

Article Title: Pre-activation and gating pathway of AMPA receptors revealed by full and partial agonists

Article References: Newton, T. P., Aktolun, M., Yelshanskaya, M. V., Alekseev, A. A., Yen, L. Y., Gangwar, S. P., Sobolevsky, I. A., Kurnikova, M. G., & Sobolevsky, A. I. (2026). Pre-activation and gating pathway of AMPA receptors revealed by full and partial agonists. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-026-01882-9

Image Credits: AI Generated

DOI: 10.1038/s41594-026-01882-9

Keywords: AMPA receptors, pre-active state, gating pathway, cryo-electron microscopy, full agonists, partial agonists, ligand-binding domain, ion channels, synaptic transmission, neuroscience, Pre-activation, gating